RxDoctor Payments Data

Gavin Pereira

Adult Reconstructive Orthopaedic Surgery · Sacramento, CANPI 1699070508

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $51,600 of the $78,230 with a category attached, or 66.0%. Stryker accounts for 80.7% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $35,348 and has fallen 55.4% since, to $15,773 in 2025.

$78,230in general payments, 2019–2025

Across 173 payments — averaging $452.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$63K
  • Musculoskeletal Transplant Foundation Inc.$6K
  • Avitus Orthopaedics, Inc.$4K
  • Zimmer Biomet$1K
  • Omnilife Science, Inc$920
  • KCI USA, Inc.$850
  • plus $2K from 13 others

What the payments were for

  • Consulting fees$51,60066%
  • Speaking & faculty fees$4,0005%
  • Travel & lodging$13,22017%
  • Food & beverage$9,41012%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$78,230 in reported general payments places this provider in the 75th percentile of 136 adult reconstructive orthopaedic surgery providers in California.

See all adult reconstructive orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$167,314
Medicare patients
275
Services billed
500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib48$812
Doxycycline Hyclate20$716
Amoxicillin78$291
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim19$219
Alendronate Sodium26$216
Gabapentin24$149
Meloxicam25$107
Azithromycin18$71

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →